key: cord-0326062-13vnd9lo
authors: Heindel, Daniel W.; Koppolu, Sujeethraj; Zhang, Yue; Kasper, Brian; Meche, Lawrence; Vaiana, Christopher; Bissel, Stephanie J.; Carter, Chalise E.; Kelvin, Alyson A.; Zhang, Bin; Zhou, Bin; Chou, Tsui-Wen; Lashua, Lauren; Ross, Ted M.; Ghedin, Elodie; Mahal, Lara K.
title: Glycomic analysis of host-response reveals high mannose as a key mediator of influenza severity
date: 2020-04-23
journal: bioRxiv
DOI: 10.1101/2020.04.21.054098
sha: e6218bc44d36a0a5c76d854181857170d071b1c2
doc_id: 326062
cord_uid: 13vnd9lo

Influenza virus infections cause a wide variety of outcomes, from mild disease to 3-5 million cases of severe illness and ~290,000-645,000 deaths annually worldwide. The molecular mechanisms underlying these disparate outcomes are currently unknown. Glycosylation within the human host plays a critical role in influenza virus biology. However, the impact these modifications have on the severity of influenza disease has not been examined. Herein, we profile the glycomic host responses to influenza virus infection as a function of disease severity using a ferret model and our lectin microarray technology. We identify the glycan epitope high mannose as a marker of influenza virus-induced pathogenesis and severity of disease outcome. Induction of high mannose is dependent upon the unfolded protein response (UPR) pathway, a pathway previously shown to associate with lung damage and severity of influenza virus infection. Also, the mannan-binding lectin (MBL2), an innate immune lectin that negatively impacts influenza outcomes, recognizes influenza virus-infected cells in a high mannose dependent manner. Together, our data argue that the high mannose motif is an infection-associated molecular pattern on host cells that may guide immune responses leading to the concomitant damage associated with severity. SIGNIFICANCE Influenza virus infection causes a range of outcomes from mild illness to death. The molecular mechanisms leading to these differential host responses are currently unknown. Herein, we identify the induction of high mannose, a glycan epitope, as a key mediator of severe disease outcome. We propose a mechanism in which activation of the unfolded protein response (UPR) upon influenza virus infection turns on expression of high mannose, which is then recognized by the innate immune lectin MBL2, activating the complement cascade and leading to subsequent inflammation. This work is the first to systematically study host glycomic changes in response to influenza virus infection, identifying high mannose as a key feature of differential host response.

currently unknown. Herein, we identify the induction of high mannose, a glycan 23 epitope, as a key mediator of severe disease outcome. We propose a mechanism in 24 which activation of the unfolded protein response (UPR) upon influenza virus 25 infection turns on expression of high mannose, which is then recognized by the 26 innate immune lectin MBL2, activating the complement cascade and leading to 27 subsequent inflammation. This work is the first to systematically study host glycomic 28 changes in response to influenza virus infection, identifying high mannose as a key 29 feature of differential host response. 30

Influenza virus infections cause ~290,000-645,000 deaths (1) and 3-5 million 33 cases of severe illness annually worldwide (2). Viral infection begins in the upper 34 respiratory tract. It can lead to airway inflammation in the lungs and, in severe cases, 35

pneumonia. The molecular mechanisms that underlie disparate outcomes of mild, 36 moderate, and severe illness are currently unknown. 37

Glycosylation within the human host plays a critical role in influenza biology 38 Studies of influenza in model organisms, such as mice, commonly use strains 50 of the virus adapted to the sialic acid receptors prevalent in the upper respiratory 51 tract of these hosts (i.e. α-2,3-linked sialosides), which differ from α-2,6-sialosides 52 found in the human respiratory tract. Ferrets, however, have a similar glycan 53 distribution in their respiratory system to humans, i.e. α-2,6-linked sialic acids and 54 low levels of N-glycolyl sialosides in the upper respiratory tract. This makes them a 55 more representative model for human biology, enabling the use of un-adapted 56 human strains of influenza (5). 57

Here, we ask whether glycosylation might play a role in the outcome of 58 influenza virus infection. We analyzed ferret host response in the lung to the 2009 59 pandemic H1N1 (H1N1pdm09) influenza virus using our lectin microarray 60 controls. In contrast, ferrets with mild infections displayed a smaller increase in high 123 mannose levels (~12-19%, dependent on lectin). 124

Overall, our lectin microarray data argues that although we see changes in 125 sialic acids with infection, they have no correlation with severity. Rather, high 126 mannose, an epitope not typically associated with influenza pathogenesis, appears 127 to directly correlate with severity. ferrets. In general, we observed a correlation between damage to the lung, as 137 defined by consolidation and inflammatory cell infiltrate, and staining with the high 138 mannose binding lectin HHL (Fig. 2a) . In normal lung, HHL staining was confined to 139 the bronchiole epithelium and basement membrane. In contrast, in infected and 140 consolidated lung tissues we observed binding to compacted alveolar spaces and 141 bronchial plugs. We also observed binding to inflammatory cells and sloughed 142 bronchial epithelium. We observe a strong correlation between HHL staining and the 143 alveolar severity score, which reflects alveolar damage and inflammation caused by 144 the infection (Fig. 2b) . Overall, our data shows that high mannose is associated with 145 both direct damage to the lungs, observed by histology, and overall illness levels, 146 observed by weight loss. To examine whether glycomic changes in the host occur early or late in 156 influenza pathogenesis, we performed a time-course analysis where infected ferrets 157 were sacrificed at days 1, 3, 5, 8, and 14 (n=12 for days 1-3, n=8 for day 5, n=19 for 158 day 8, n=8 for day 14, for a total of 59 ferrets). We analyzed 2 lung punch biopsies 159 per ferret. The time course experiments and our previously discussed analysis were 160 performed concurrently and analyzed on the same set of arrays. Thus, data for day 161 8 ferrets and control (day 0) samples are the same as in Figure 1a . High mannose, which correlates to severity at day 8, was strongly induced in 180 some ferrets at day 1 (Fig. 3a) . At this early time point we are unable to predict 181 whether ferrets with higher levels of high mannose have a more severe 182 immunological response to influenza virus infection overall. However, HHL staining 183 of virally infected lungs from ferrets sacrificed at day 1 correlated with damage in the 184 lung tissue (Fig. 3b) , similar to observations at day 8 (Fig. 2a) . This strongly 185

suggests that high mannose is induced immediately upon infection with influenza 186 virus and that the levels of the epitope are directly correlated with severity even at 187 the early time points. cells, we treated primary bronchial epithelia with PR8 and analyzed them as 207 described. Again, we observed a strong increase in high mannose in response to 208 viral infection (Fig. 4b) . Infection of A549 cells with other influenza strains 209 (H1N1pdm09, H3N2, influenza B, Fig. 4c) , also resulted in an increase in high 210 mannose, indicating that the response is not strain specific. 211

Given that high mannose is a precursor in the N-glycan pathway, a question 212 that arises is whether high mannose could act as an independent signal without 213 impacting complex N-glycan levels. Recent studies have shown that the trimming 214 mannosidases, MAN1A1 and MAN1A2 can be independently deleted without highly regulated by miRNA (31), and miRNA downregulating MAN1A2 increased 217 high mannose without decreasing core fucose, a marker of complex N-glycans (11). 218

To test this more directly, we performed lectin microarray analysis of A549 cells 219 infected with PR8 (Fig. 5a, Supplemental Fig. 10 ). In line with our observation in 220 ferret lungs and our microscopy data, we again observed an increase in high 221 mannose (GRFT, SVN, HHL, UDA). However, we did not observe a corresponding 222 virus glycoproteins (Fig. 5b, Supplemental Fig. 11) . Upon infection, we detect 240 increased levels of high mannose across multiple proteins, both influenza and host, 241 as determined by HHL binding. We observed a strong increase in high mannose for 242 a band correlating to NA (indicated by arrows, Fig. 5b) . Quantitation of the lectin 243 blot, excluding presumed HA and NA proteins, reveals a 120% increase in HHL of key UPR markers HSP90B1 (also known as Grp94) and HYOU1 (40) in ferret lung 259 on day 1 post-infection (Fig. 6a) . This indicates that UPR is rapidly induced by (Fig. 6b, Supplemental Fig. 12a ). This indicates that induction of the high 267 mannose epitope occurs downstream of the XBP1s arm of the UPR. Lectin 268 microarray analysis revealed 4μ8C inhibited high mannose but did not impact the 269 change in sialylation observed upon infection, arguing that the impact of inhibiting 270 this pathway is specific to the high mannose response (Supplemental Fig. 12b) . To test whether recognition is dependent upon the high mannose epitope, we 301 removed all high mannose and hybrid N-glycans using Endo H. Removal of these 302 glycans abolished the signal, providing evidence that the recognition is via the high 303 mannose epitope (Fig. 7) . Our data suggest a potential role for high mannose in 304 recruiting MBL2 to host tissue in influenza virus infection; this could contribute to 305 severity through activation of the complement cascade and corresponding 306 inflammatory response. 307

Lectin-glycan interactions play a major role in infectious disease, impacting 310 all stages from colonization to disease progression and host response (50-52) . activating the complement cascade and subsequent inflammation (Fig. 8) . Inhibition 323 of the complement cascade with C3a inhibitors reduces damage in H5N1 influenza 324 virus-infected mice, providing additional evidence for our hypothesis (53). Our results 325

indicate that high mannose can be induced through the UPR upon influenza infection 326 (Fig. 6, Supplemental Fig. 12) . The use of high mannose by the cell, as a type of 327 damage or distress signal, makes sense as it is not detected at the cell surface on 328 most cell types, but is recognized by a significant number of innate immune lectins, 329

including MBL2 (Fig. 7) (12). In addition, high mannose has the potential for 330 independent regulation from the complex N-glycan pool (Fig. 5a) (11, 29-31) . Taken 331 together, our work provides a new mechanism that could explain the observation 332 that both UPR activation and MBL2 levels directly associate with severity of outcome 333 from influenza infection (13, 18, 19) . 334

A picture is emerging in which high mannose could act as a signal to our (R)) of ferret lung samples were ordered by severity (uninfected, n=4 ferrets, 4 583 samples per ferret; d8 infected, n=19 ferrets (mild, n=5; moderate, n=8; severe, n=6; 584 2 samples per ferret). Yellow, log2(S) > log2(R); blue, log2(R) > log2(S). Lectins 585 binding α-2,6-sialosides (purple), α-2,3-sialosides (pink), GM1 (blue), high mannose 586 (green) and N-acetylgalactosamine (grey) are indicated on the right. b) Boxplot 587 analysis of lectin binding by SNA (α-2,6-sialosides). c) MAA (α-2,3-sialosides) and 588

HHL (high mannose) as a function of severity. (uninfected:blue, mild: yellow, 589 moderate: orange, high: red). N.S.: Not statistical, **: p < 0.01, ***: p < 0.001, 590

Wilcoxon's t-test. 591 with biotinylated HHL and avidin peroxidase (red), counterstained with hematoxylin 595 (blue). Images shown were obtained with 10x and 20x objectives resulting in 100x 596

and 200x magnification as labeled (factoring in 10x eyepiece lens). Scale bar: 100 597 μm. b) Correlation of HHL binding scores with the alveolar severity scores in 598 histology samples. The following semiquantitative scoring system was used to 599 evaluate HHL staining: 0, rare or occasional cells but <5% of fields; 1, >0.5 to 0.25 600 low-power fields; 2, >0.25 low-power fields; 3, essentially all low-power fields. 601

Scoring of alveolar severity: 0 = normal, 1 = mild, 2 = moderate, 3 = severe. Scores 602 for severity were averaged over fields. influenza nucleoprotein (anti-Flu) antibody (2°: anti-mouse IgG-Cy3, green), and 623 DAPI (blue). For Endo H controls, enzyme treatment was performed prior to staining. 624

Bright field and overlay images of DAPI, HHL and anti-Flu stained images are shown. 625

Scale bar: 100 μm. For each experiment, three biological replicates were performed 626 and a minimum of six images was captured. Representative images are shown. 627 

Estimates of global seasonal influenza-associated respiratory 441 mortality: a modelling study

Seasonal influenza: waiting for the next pandemic

The battle between influenza and the innate immune response in 445 the human respiratory tract

Glycomic characterization of respiratory tract tissues of ferrets: 448 implications for its use in influenza virus infection studies

A ratiometric lectin microarray 451 approach to analysis of the dynamic mammalian glycome

Advances in lectin microarray 454 technology: optimized protocols for piezoelectric print conditions

Development of a 457 lectin microarray for the rapid analysis of protein glycopatterns

Estimated global mortality associated with the first 12 460 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling 461 study

A Systems Biology Approach Identifies FUT8 as a Driver of

Mapping posttranscriptional regulation of the human glycome 465 uncovers microRNA defining the glycocode

Emerging roles of 468 protein mannosylation in inflammation and infection

Acute Lung Injury Results from Innate Sensing of Viruses 471 by an ER Stress Pathway

Characterization of oligosaccharide ligands expressed on 473 SW1116 cells recognized by mannan-binding protein. A highly fucosylated 474 polylactosamine type N-glycan

Highly fucosylated N-glycan ligands for mannan-binding 476 protein expressed specifically on CD26 (DPPVI) isolated from a human 477 colorectal carcinoma cell line, SW1116

Interaction of mannan binding lectin with alpha2 479 macroglobulin via exposed oligomannose glycans: a conserved feature of the 480 thiol ester protein family?

A secreted protein with plant-specific cysteine-rich motif 482 functions as a mannose-binding lectin that exhibits antifungal activity

Mannose-binding lectin contributes to deleterious 485 inflammatory response in pandemic H1N1 and avian H9N2 infection

Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill 489 Patients with Pandemic Influenza Type A (H1N1) Infection

Modeling host responses in ferrets during A/California/07/2009 492 influenza infection

Structural 494 characterization of the hemagglutinin receptor specificity from the 2009 H1N1 495 influenza pandemic

Influenza Other Respir Viruses

Characterization of the neuraminidase of the H1N1/09 499 pandemic influenza virus

Influenza virus assembly and budding in raft-derived 501 microdomains: a quantitative analysis of the surface distribution of HA, NA and 502 M2 proteins

Influenza virus-induced lung 504 injury: pathogenesis and implications for treatment

Preliminary Proteomic Analysis of A549 Cells Infected with Avian 507 Influenza Virus H7N9 and Influenza A Virus H1N1

Highly Pathogenic H5N1 and Novel H7N9 Influenza A Viruses 510 Induce More Profound Proteomic Host Responses than Seasonal and Pandemic 511 H1N1 Strains

Glycosylation in cellular mechanisms of health and 513 disease

Genetic disruption of multiple alpha1,2-mannosidases generates 515 mammalian cells producing recombinant proteins with high-mannose-type N-516 glycans

The glycosylation design space for recombinant lysosomal 518 replacement enzymes produced in CHO cells

Insights into miRNA regulation of the 520 human glycome

Expression Levels of Sialic Acid on Influenza-Virus-Infected Cells Using Lectin-523 Tagged Polymeric Nanoparticles

Influenza A surface glycosylation and vaccine design

Influenza M2 proton channels

Influenza A virus M2 ion 529 channel protein: a structure-function analysis

Influenza virus M2 protein is an 531 integral membrane protein expressed on the infected-cell surface

Influenza A viral replication is blocked by inhibition of the 534 inositol-requiring enzyme 1 (IRE1) stress pathway

XBP1s Links the Unfolded Protein Response to the Molecular 537 Architecture of Mature N-Glycans

XBP1s activation can globally remodel N-glycan structure 539 distribution patterns

Stress-independent activation of XBP1s and/or ATF6 541 reveals three functionally diverse ER proteostasis environments

The molecular basis for selective inhibition of unconventional 544 mRNA splicing by an IRE1-binding small molecule

Recognition of microbial glycans by 547 soluble human lectins

Complement-549 dependent neutralization of influenza virus by a serum mannose-binding 550 lectin

The role of mannose-binding lectin in health and disease

Mannose binding lectin 554 mediated complement pathway in multiple sclerosis

Epidemiology of 557 multiple sclerosis: results from a large observational study in the UK

Among Adults With Schizophrenia in the United States

MBL and MASP-2 concentrations in serum and MBL2 563 promoter polymorphisms are associated to schizophrenia

A serum mannose-566 binding lectin mediates complement-dependent lysis of influenza virus-567 infected cells

Infection, inflammation and host carbohydrates: a 569 Glyco-Evasion Hypothesis

Coupling pathogen 571 recognition to innate immunity through glycan-dependent mechanisms

Virus recognition of glycan 574 receptors

Inhibition of complement activation alleviates acute lung injury 576 induced by highly pathogenic avian influenza H5N1 virus infection

Imbalanced host response to SARS-CoV-2 drives 579 development of COVID-19. Cell ePub ahead of print

High mannose was induced at early time points in response to 608 influenza virus infection. a) Boxplot analysis of high mannose (HHL-binding) at 609 different time points following H1N1pdm09 virus infection

Severity is 611 indicated by color (green: uninfected, black: early for severity, dark yellow: mild, 612 orange: moderate, red: severe). b) Lectin histology of ferret lung tissue. FFPE 613 tissues were stained with biotinylated HHL developed with avidin peroxidase (red) 614 and counterstained with hematoxylin (blue)

High mannose is induced via the unfolded protein response

Boxplot analysis of transcript levels of UPR markers HSP90B1 and HYOU1 in lung 647 tissues from H1N1pdm09 infected ferrets from time course analysis. b) Fluorescence 648 microscopy of A549 cells treated with IRE1 inhibitor 4μ8C (24 h) prior to infection

Cells were fixed, stained and imaged as previously described. Scale bar: 100 μm

For each experiment, three biological replicates were performed and a minimum of 651 six images was captured. Representative images are shown. Lectin microarray 652 analysis of A549 cells treated as in b is shown in Supplemental Figure 12b

MBL2 658 staining of A549 cells. A549 cells (PR8 infected (24 h), and Control) were incubated 659 with recombinant human MBL2 and stained with mouse anti-MBL (Biotin) antibody 660 (2°:Cy3 Streptavidin, red)

The 

infection medium and incubated in the infection medium for 8, 6, or 24 h, as indicated 400 prior to harvesting. Control cells were treated identically, however no PR8 virus was 401 added to the media. IRE1 inhibition: Cells were seeded at a density of 120,000 cells 402in 35 mm glass-bottom dishes and grown in standard condition. After 24 h cells were 403 treated with either IRE1 inhibitor 4μ8C (64 μM) or DMSO (Control). After an 404 additional 24 h, cells were treated with PR8 virus as described above. For IRE1 405 inhibitor treated cells, 4μ8C (64 μM) was maintained in the culture media throughout 406 the infection. All cells were then either lysed for Western blot analysis, processed for 407 lectin microarray analysis (7), or fixed and stained for fluorescence imaging. were imaged by fluorescence microscopy as described above. Endo H treated 439 controls were prepared as described above. 440 (biotinylated HHL (20 μg/mL) followed by streptavidin HRP (1:5000)). HA and NA 640 proteins are indicated by arrows. Even loading was checked by Ponceau 641 (Supplemental Fig. 11 ). 642 643